Related Experiment Video
Updated: Feb 10, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B
Insights
Hepatitis B virus (HBV) core gene mutations impact immune responses. Ultra-deep pyrosequencing revealed mutation patterns in T helper, cytotoxic T lymphocyte, and B cell epitopes, with higher frequencies in the C-terminal region, especially in patients with advanced fibrosis.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Hepatitis B virus (HBV) core protein is crucial for immune response.
- Mutations in the HBV core gene can alter key epitopes, affecting host immunity.
- The long-term impact of core gene mutations on HBV infection remains unclear.
Purpose of the Study:
- To analyze core gene mutations in T lymphocyte (Th and CTL) and B cell epitopes, and the C-terminal region.
- To investigate these mutations in chronic hepatitis B patients using ultra-deep pyrosequencing (UDPS).
Main Methods:
- Eleven chronic hepatitis B patients were studied.
- HBV core gene was amplified using conventional PCR.
- UDPS was employed to screen mutations in T lymphocyte (Th and CTL) and B cell epitopes, and the C-terminal region.
- Mutations were analyzed in HBeAg positive and negative patients.
Main Results:
- Amino acid substitutions ranged from 0.9% (HBeAg positive) to 1.2% (HBeAg negative).
- Higher missense mutation rates were observed in HBeAg positive patients (p < 0.005).
- The aa49-69 region showed the highest amino acid substitutions in Th epitopes.
- C-terminal region mutations were more frequent than in Th, CTL, and B cell regions, and associated with high-grade fibrosis.
- Specific mutations (V27I, R47H, Y132I, R174STOP, S181P, Q182K) were exclusively found in cirrhotic patients.
Conclusions:
- Contrary to existing literature, no significant increase in core gene mutations was observed during the anti-HBe positive period.
- UDPS facilitates understanding the role of low-abundance variants and mutations in the immune system.
Background:
The HBV core protein plays a major role in host immune response. Mutations occurring in the HBV core gene may cause alterations in the major epitopes being effective in the host immune response. Until now, the persistent effects of core gene mutations on HBV infections have not been fully understood. The aim of this study is to analyze the core gene mutations for epitopes in the T lymphocytes [T helper (Th) and cytotoxic (CTL)] and B cell and C terminal region in patients with chronic hepatitis using ultra-deep pyrosequencing (UDPS) method.
Methods:
Eleven patients with chronic hepatitis B infection were included in the study. Amplification of the core gene was performed by a conventional PCR method. Mutations in the epitopes for T lymphocytes (Th and CTL) and B cell and in the C terminal region of HBV core gene were screened by UDPS. These mutations were analyzed in HBeAg positive and negative patients.
Results:
The minimum percentages of amino acid substitutions were found with 0.9% in HBeAg positive patients and 1.2% in negative patients. The number of missense mutation was higher in patients with HBeAg positive than negative patients (p < 0.005). The number of amino acid substitutions in the region of aa49 - 69 in the Th epitopes was found to be the highest in both HBeAg positive and negative patients. The mutation frequency was higher in the C-terminal region of the core protein compared to the Th, CTL, and B cell regions and these were more common in subjects with high-grade fibrosis. Some types of mutations (V27I, R47H, Y132I, R174STOP, S181P, Q182K) were only detected in subjects with liver cirrhosis.
Conclusions:
Unlike literature, our results show that there is no significant increase in number of mutations in the core gene of the virus during the anti-HBe positive period. The role of low abundance variants and mutations in the immune system can be understood using methods such as UDPS in the near future.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Mutation, Gene Flow, and Genetic Drift
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters

